drugset / Trial / NCT01673828
Allopregnanolone for the Treatment of Traumatic Brain Injury
Phase 2
Completed
13 enrolled
Michael A. Rogawski, MD, PhD
United States Department of Defense · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will provide initial data on the safety and effectiveness of allopregnanolone in improving neurobehavioral outcome and reducing mortality in adults with moderate and severe traumatic brain injury.
Timeline
- Start
- 2013-04
- Primary completion
- 2015-05
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allopregnanolone | Small molecule | — | Intravenous |